BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B
Authors:
- Matthew A. CoelhoMCMatthew A. Coelho
- Songyuan LiSLSongyuan Li
- Luna Simona PaneLPLuna Simona Pane
- Mike FirthMFMike Firth
- Giovanni CiottaGCGiovanni Ciotta
- Jonathan D. WrigleyJWJonathan D. Wrigley
- Maria Emanuela CuomoMCMaria Emanuela Cuomo
- Marcello MarescaMMMarcello Maresca
- Benjamin J. M. TaylorBTBenjamin J. M. Taylor
Open Access
- 28 December 2018
- journal article
- research article
- Published by Springer Nature in BMC Biology
- Vol. 16 (1) , 150
Abstract
Base Editing is a precise genome editing method that uses a deaminase-Cas9 fusion protein to mutate cytidine to thymidine in target DNA in situ without the generation of a double-strand break. However, the efficient enrichment of genetically modified cells using this technique is limited by the ability to detect such events. We have developed a Base Editing FLuorescent Activity REporter (BE-FLARE), which allows for the enrichment of cells that have undergone editing of target loci based on a fluorescence shift from BFP to GFP. We used BE-FLARE to evaluate the editing efficiency of APOBEC3A and APOBEC3B family members as alternatives deaminase domains to the rat APOBEC1 domain used in base editor 3 (BE3). We identified human APOBEC3A and APOBEC3B as highly efficient cytidine deaminases for base editing applications with unique properties. Using BE-FLARE to report on the efficiency and precision of editing events, we outline workflows for the accelerated generation of genetically engineered cell models and the discovery of alternative base editors.Keywords
This publication has 33 references indexed in Scilit:
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Obligate Ligation-Gated Recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joiningGenome Research, 2012
- Tracking genome engineering outcome at individual DNA breakpointsNature Methods, 2011
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- The T790M “gatekeeper” mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitorMolecular Cancer Therapeutics, 2008
- Differential Constitutive Activation of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer Cells BearingEGFRGene Mutation and AmplificationCancer Research, 2007
- Editors' ReplyPLOS Medicine, 2005
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase DomainPLOS Medicine, 2005
- AID Enzyme-Induced Hypermutation in an Actively Transcribed Gene in FibroblastsScience, 2002
- Systematic Determination of the Packaging Limit of Lentiviral VectorsHuman Gene Therapy, 2001